Correlation Between PTC Therapeutics and Annexon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PTC Therapeutics and Annexon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PTC Therapeutics and Annexon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PTC Therapeutics and Annexon, you can compare the effects of market volatilities on PTC Therapeutics and Annexon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PTC Therapeutics with a short position of Annexon. Check out your portfolio center. Please also check ongoing floating volatility patterns of PTC Therapeutics and Annexon.

Diversification Opportunities for PTC Therapeutics and Annexon

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between PTC and Annexon is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding PTC Therapeutics and Annexon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexon and PTC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PTC Therapeutics are associated (or correlated) with Annexon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexon has no effect on the direction of PTC Therapeutics i.e., PTC Therapeutics and Annexon go up and down completely randomly.

Pair Corralation between PTC Therapeutics and Annexon

Given the investment horizon of 90 days PTC Therapeutics is expected to generate 0.94 times more return on investment than Annexon. However, PTC Therapeutics is 1.06 times less risky than Annexon. It trades about 0.11 of its potential returns per unit of risk. Annexon is currently generating about -0.03 per unit of risk. If you would invest  3,519  in PTC Therapeutics on August 28, 2024 and sell it today you would earn a total of  780.00  from holding PTC Therapeutics or generate 22.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

PTC Therapeutics  vs.  Annexon

 Performance 
       Timeline  
PTC Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PTC Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, PTC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Annexon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Annexon has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

PTC Therapeutics and Annexon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PTC Therapeutics and Annexon

The main advantage of trading using opposite PTC Therapeutics and Annexon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PTC Therapeutics position performs unexpectedly, Annexon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexon will offset losses from the drop in Annexon's long position.
The idea behind PTC Therapeutics and Annexon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes